藥物投遞市場Vol.Ⅲ：肺部輸送系統 是由出版商Kalorama Information在2007年03月所出版的。
這份英文市場調查報告書包含132 pages 價格從美金2495起跳。
Abstract
The lungs are considered by many to be the best alternative for drugs needing
to bypass the gastrointestinal tract. With advancing technology, the practice
of utilizing the huge surface area of the lungs to delivery drugs into the
blood circulation has been slowly transforming into reality.
The pulmonary drug delivery market reached $25.5 billion in 2006 and is
expected to experience high steady growth in the next five years. Contributing
to growth are new technologies such as dry powder inhalers and new product
offerings that require advanced drug delivery. Pulmonary drug delivery offers
the potential for noninvasive administration of a wide variety of
macromolecules. Nearly every biotherapeutic product that treats chronic or
long-term illness would benefit from noninvasive delivery by providing a
competitive advantage with current therapeutics. This advantage could expand
the market for each product or enable new indications to be considered.
Kalorama' s Drug Delivery Markets. Edition 2 Volume III: Pulmonary Delivery
Systems, the third volume of Kalorama' s popular series focusing on global drug
delivery systems markets, provides the definitive break down of the market for
pulmonary delivery system markets. The report covers both pharmaceuticals sold
through pulmonary delivery systems and the technologies themselves
The report provides current market size and revenue for the following main
categories:
- Inhalation drug delivery
- Intranasal drug delivery
Kalorama believes the future of drug administration by inhalation will expand
vastly and be a significant driver in this market. Serious market-watchers who
are looking at new products or ways to expand existing products will find this
information essential.
As part of its comprehensive cooverage, Kalorama' s report includes:
- A Breakdown of Demographics and Trends that will drive pulmonary
delivery.
- New Developments including Prodrug Technology, Electrohydrodynamic
Aerosol Delivery, Oxygen Delivery and Crystallization Technology
- Detailed Discussion of Current Products in pulmonary drug delivery.
- Current Market Size and Forecasts to 2010.
- Review of Pipleline products
- Profiles of Key Companies in the Pulmonary Delivery markets.
As part of Kalorama' s trusted information-gathering process, industry
executives are consulted. While government and company data is culled, it is
interviews with executives that provide the foundation for market sizes and
forecasts.
Kalorama' s coverage of the pulmonary drug delivery market includes coverage of
the following companies in this field:
- 3M
- Alkermes
- Aradigm
- Elan
- Nastech
- Nektar
- SkyePharma
Table of Contents
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- The Total Pulmonary Drug Delivery Only Market
- Competitor and Market Analysis
Chapter two: Introduction and Overview
- Scope and Methodology
- Reasons for pulmonary Drug Delivery Systems
- History and Mechanics of Pulmonary Drug Delivery
- Phases of Drug Action
- Pharmacokinetics of Inhalation
- Inhalation Delivery Technologies
- Metered Dose Inhalers
- Dry Powder Formulations
- Nebulizer Delivery Formulations
- Liquid Formulations
- Nanospheres
- Intranasal Delivery Technologies
Chapter three: Trends and Demographics
- Asthma
- Opportunities for Drug Delivery System Success
- Exubera Breakthrough
- Nano and Microparticulate Systems
- Trends in Liquid Aerosols
- CFC Phase Out
- Expansion of Biotechnology
- Macromolecule Delivery
Chapter four: New Developments
- Prodrug Drug Delivery
- Electrohydrodynamic Aerosol Delivery
- Oxygen Delivery
- Crystallization Technology
Chapter five: Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- Pulmonary Delivery Technology Only Market
Chapter six: Competitive and Market Analysis
- Competitor Analysis
- Market Analysis
Chapter seven: Company Profiles
- 3M Pharmaceuticals
- Alkermes, Inc.
- Aradigm Corporation
- Elan Corporation, Plc
- Innovata BioMed Plc
- MicroDose Technology, Inc
- Nastech Pharmaceutical Company Inc.
- Nektar Therapeutics
- Oriel Therapeutics
- Pipex Pharmaceuticals
- Resiprics, Inc.
- SkyePharma Plc
- Vectura Ltd.
- Ventaira Pharmaceuticals, Inc.
Chapter eight: Companies in Brief
- Bespak
- Direct Haler A/S
- IntraNasal Therapeutics
Appendix: Company Directory
TAble of exhibits
Chapter one: Executive Summary
- Table 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and
Pharmaceuticals 2002-2010
- Figure 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology
and Pharmaceuticals 2002-2010
- Table 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems by
Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Chapter two: Introduction and Overview
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Demographics
- Table 3-1: Worldwide Prevalence of Asthma 2006
- Figure 3-1: Worldwide Prevalence of Asthma 2006
- Table 3-2: World Population by Age Group 2002-2010
- Figure 3-2: World Population by Age Group 2002-2010
Chapter fivE: Market Size and Growth
- Table 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and
Pharmaceuticals 2002-2010
- Figure 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology
and Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary
Drug Delivery Systems by Type 2002-2010
- Figure 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary
Drug Delivery Systems Revenues by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary
Drug Delivery Technologies Market Share by Type 2002-2010
- Figure 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary
Drug Delivery Technologies by Type 2006
- Figure 5-4: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary
Drug Delivery Technologies by Type 2010
- Table 5-4: The Worldwide Market for Pulmonary Drug Delivery Systems by
Pharmaceutical and Drug Delivery Component 2002-2010
- Table 5-5 of Revenue by Pharmaceutical and Drug Delivery Component
2002-2010
- Figure 5-5 of Revenue by Pharmaceutical and Drug Delivery Component
2002-2010
- Figure 5-6: The Worldwide Market for Pulmonary Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 5-7: The Worldwide Market for Pulmonary Drug Delivery Systems
Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
Chapter six: Competitive and Market Analysis
- Table 6-1: Selected Leading and Emerging Suppliers of Pulmonary Drug
- Delivery Technology
